HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Susan A Maroney Selected Research

lipoprotein-associated coagulation inhibitor (TFPI)

1/2022Factor V east Texas variant causes bleeding in a three-generation family.
1/2021The contribution of TFPIα to the hemostatic response to injury in mice.
11/2019Measurement of plasma and platelet tissue factor pathway inhibitor, factor V and Protein S in people with haemophilia.
9/2018Plasma Proteolytic Cascade Activation during Neonatal Cardiopulmonary Bypass Surgery.
1/2018Suppressive Role of Tissue Factor Pathway Inhibitor-α in Platelet-Dependent Fibrin Formation under Flow Is Restricted to Low Procoagulant Strength.
1/2018Correlates of plasma and platelet tissue factor pathway inhibitor, factor V, and Protein S.
2/2017Reduced Prothrombinase Inhibition by Tissue Factor Pathway Inhibitor Contributes to the Factor V Leiden Hypercoagulable State.
5/2016Targeting TFPI for hemophilia treatment.
6/2015A balance between TFPI and thrombin-mediated platelet activation is required for murine embryonic development.
5/2014Biology of tissue factor pathway inhibitor.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Susan A Maroney Research Topics

Disease

9Thrombosis (Thrombus)
01/2021 - 03/2007
8Hemorrhage
01/2022 - 03/2012
5Hemophilia A (Haemophilia)
11/2019 - 03/2012
3Vascular System Injuries
01/2021 - 04/2011
1Wounds and Injuries (Trauma)
01/2021
1Hemophilia B (Haemophilia B)
11/2019
1Congenital Heart Defects (Congenital Heart Defect)
09/2018
1Thrombophilia
02/2017
1Disseminated Intravascular Coagulation
06/2015
1Inflammation (Inflammations)
06/2015
1Pulmonary Embolism
06/2015
1Pneumonia (Pneumonitis)
09/2013
1Sepsis (Septicemia)
09/2013
1Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
02/2008
1Venous Thrombosis (Deep-Vein Thrombosis)
02/2008

Drug/Important Bio-Agent (IBA)

16lipoprotein-associated coagulation inhibitor (TFPI)IBA
01/2022 - 03/2007
5FibrinIBA
01/2021 - 03/2007
4ThrombinFDA Link
01/2021 - 03/2012
4Thromboplastin (Tissue Factor)IBA
06/2015 - 03/2007
3Proteins (Proteins, Gene)FDA Link
11/2019 - 05/2016
2Factor V (Coagulation Factor V)IBA
01/2022 - 11/2019
2Oral ContraceptivesIBA
02/2017 - 02/2008
2Factor VIII (Coagulation Factor VIII)IBA
05/2016 - 03/2012
2AnticoagulantsIBA
05/2016 - 05/2014
1Hemostatics (Antihemorrhagics)IBA
01/2021
1AntigensIBA
11/2019
1Protein SIBA
11/2019
1Protease Inhibitors (Protease Inhibitor)IBA
09/2018
1CollagenIBA
01/2018
1factor V LeidenIBA
02/2017
1Factor IX (Coagulation Factor IX)FDA LinkGeneric
05/2016
1estropipate (Ogen)FDA LinkGeneric
06/2015
1AntithrombinsIBA
06/2015
1Protein Isoforms (Isoforms)IBA
05/2014
1Pharmaceutical PreparationsIBA
09/2013
1ferric chlorideIBA
09/2010

Therapy/Procedure

1Punctures
01/2021
1Cardiopulmonary Bypass (Heart-Lung Bypass)
09/2018